TTR and axial length measurement: In our study, we analyzed data from 63 patients with Amyloid light-chain amyloidosis AL (40%), 82 with wild-type Amyloid Transthyretine (ATTR) (52%), and 12 patients with variant ATTR (8%) (Table S2).